Louise Zhou, MD | |
2711 X Ray Dr Ste 3701, Gastonia, NC 28054 | |
(980) 834-9600 | |
(980) 834-9605 |
Full Name | Louise Zhou |
---|---|
Gender | Female |
Speciality | Hematology/oncology |
Experience | 16 Years |
Location | 2711 X Ray Dr Ste 3701, Gastonia, North Carolina |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003075490 | NPI | - | NPPES |
003110407B | Medicaid | GA | |
1003075490 | Medicaid | NC | |
NC3769 | Medicaid | SC | |
003837700 | Medicaid | FL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RX0202X | Internal Medicine - Medical Oncology | 2016-01337 (North Carolina) | Secondary |
207RH0003X | Internal Medicine - Hematology & Oncology | MD61108658 (Washington) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Virginia Mason Memorial | Yakima, WA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Kaiser Foundation Health Plan Of Washington | 9032022579 | 1480 |
Yakima Valley Memorial Physicians | 1557391596 | 250 |
News Archive
Some treatments for brain and spine tumors traditionally have involved restraining a patient with a heavy immobilization device and pins that pierce the skin and embed into the skull to ensure the accuracy and precision of a treatment. Doctors say the pins can add considerable anxiety.
A Nevada Senate-Assembly budget subcommittee has voted to reject some of the changes to the $900 million state Medicaid budget proposed by Gov. Jim Gibbons (R) and others, the AP/San Jose Mercury News reports (Gines, AP/San Jose Mercury News, 5/12).
Baxter International Inc. today announced that the company has submitted a supplemental biologics license application (sBLA) to the U.S. Food and Drug Administration (FDA) for approval of GAMMAGARD LIQUID 10% for the treatment of multifocal motor neuropathy.
Injection drug users who undergo surgery for infective endocarditis (IE) have a significantly higher risk of reoperation or death between 3 and 6 months after surgery compared to patients who develop endocarditis who are not IV drug abusers, according to an article in the September 2015 issue of The Annals of Thoracic Surgery.
› Verified 9 days ago
Entity Name | Kaiser Foundation Health Plan Of Washington |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396810701 PECOS PAC ID: 9032022579 Enrollment ID: O20031112000454 |
News Archive
Some treatments for brain and spine tumors traditionally have involved restraining a patient with a heavy immobilization device and pins that pierce the skin and embed into the skull to ensure the accuracy and precision of a treatment. Doctors say the pins can add considerable anxiety.
A Nevada Senate-Assembly budget subcommittee has voted to reject some of the changes to the $900 million state Medicaid budget proposed by Gov. Jim Gibbons (R) and others, the AP/San Jose Mercury News reports (Gines, AP/San Jose Mercury News, 5/12).
Baxter International Inc. today announced that the company has submitted a supplemental biologics license application (sBLA) to the U.S. Food and Drug Administration (FDA) for approval of GAMMAGARD LIQUID 10% for the treatment of multifocal motor neuropathy.
Injection drug users who undergo surgery for infective endocarditis (IE) have a significantly higher risk of reoperation or death between 3 and 6 months after surgery compared to patients who develop endocarditis who are not IV drug abusers, according to an article in the September 2015 issue of The Annals of Thoracic Surgery.
› Verified 9 days ago
Entity Name | Yakima Valley Memorial Physicians |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1306933940 PECOS PAC ID: 1557391596 Enrollment ID: O20050818000714 |
News Archive
Some treatments for brain and spine tumors traditionally have involved restraining a patient with a heavy immobilization device and pins that pierce the skin and embed into the skull to ensure the accuracy and precision of a treatment. Doctors say the pins can add considerable anxiety.
A Nevada Senate-Assembly budget subcommittee has voted to reject some of the changes to the $900 million state Medicaid budget proposed by Gov. Jim Gibbons (R) and others, the AP/San Jose Mercury News reports (Gines, AP/San Jose Mercury News, 5/12).
Baxter International Inc. today announced that the company has submitted a supplemental biologics license application (sBLA) to the U.S. Food and Drug Administration (FDA) for approval of GAMMAGARD LIQUID 10% for the treatment of multifocal motor neuropathy.
Injection drug users who undergo surgery for infective endocarditis (IE) have a significantly higher risk of reoperation or death between 3 and 6 months after surgery compared to patients who develop endocarditis who are not IV drug abusers, according to an article in the September 2015 issue of The Annals of Thoracic Surgery.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Louise Zhou, MD 10452 Silverdale Way Nw, Silverdale, WA 98383-9411 Ph: (360) 307-7300 | Louise Zhou, MD 2711 X Ray Dr Ste 3701, Gastonia, NC 28054 Ph: (980) 834-9600 |
News Archive
Some treatments for brain and spine tumors traditionally have involved restraining a patient with a heavy immobilization device and pins that pierce the skin and embed into the skull to ensure the accuracy and precision of a treatment. Doctors say the pins can add considerable anxiety.
A Nevada Senate-Assembly budget subcommittee has voted to reject some of the changes to the $900 million state Medicaid budget proposed by Gov. Jim Gibbons (R) and others, the AP/San Jose Mercury News reports (Gines, AP/San Jose Mercury News, 5/12).
Baxter International Inc. today announced that the company has submitted a supplemental biologics license application (sBLA) to the U.S. Food and Drug Administration (FDA) for approval of GAMMAGARD LIQUID 10% for the treatment of multifocal motor neuropathy.
Injection drug users who undergo surgery for infective endocarditis (IE) have a significantly higher risk of reoperation or death between 3 and 6 months after surgery compared to patients who develop endocarditis who are not IV drug abusers, according to an article in the September 2015 issue of The Annals of Thoracic Surgery.
› Verified 9 days ago
Anthony R Arn, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2555 Court Dr, Suite 300, Gastonia, NC 28054 Phone: 704-868-3256 Fax: 704-868-5870 | |
Douglas A Nigbor, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2544 Court Dr, Ste F, Gastonia, NC 28054 Phone: 704-864-8302 Fax: 704-864-0228 | |
Ajaykumar Narandas Patel, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2525 Court Dr, Gastonia, NC 28054 Phone: 704-834-2000 Fax: 704-834-2500 | |
Dr. Yi Zhang, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 2544 Court Dr Ste F, Gastonia, NC 28054 Phone: 704-864-8302 Fax: 704-864-0228 | |
Dr. Shawnya Ayers Gore, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1867 Remount Rd, Suite D, Gastonia, NC 28054 Phone: 704-854-8799 Fax: 704-854-8803 | |
Richard Alan Fricker, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 2240 Remount Rd, Gastonia, NC 28054 Phone: 704-671-5344 Fax: 704-671-5331 |